Showing results (61-70 of 738) with videos related to
Sort By:
Pageof 74
Clinical and Experimental Rheumatology|October 8, 2014
Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonismIain B McInnes, Simon Cruwys, Keith Bowers, et al.Modern Rheumatology|March 19, 2021
Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trialsYoshiya Tanaka, Arthur Kavanaugh, Jason Wicklund, et al.Journal of Leukocyte Biology|January 30, 2003
Interleukin-18J Alastair Gracie, Susan E Robertson, Iain B McInnesAtherosclerosis|October 17, 2016
Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritisPaul Welsh, Katie Tuckwell, Iain B McInnes, et al.The Lancet. Psychiatry|October 28, 2018
Rheumatoid arthritis and depression: an inflammatory perspectiveLouis Nerurkar, Stefan Siebert, Iain B McInnes, et al.Nature Reviews. Immunology|January 19, 2010
Disease-associated functions of IL-33: the new kid in the IL-1 familyFoo Y Liew, Nick I Pitman, Iain B McInnesNature Reviews. Rheumatology|December 15, 2015
Cytokines in rheumatoid arthritis - shaping the immunological landscapeIain B McInnes, Christopher D Buckley, John D IsaacsCurrent Opinion in Rheumatology|May 1, 2002
Novel pathways that regulate tumor necrosis factor-alpha production in rheumatoid arthritisJ Alastair Gracie, Bernard P Leung, Iain B McInnesClinical, Cosmetic and Investigational Dermatology|March 14, 2024
Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast]Joseph F Merola, Ahmad Z AminThe Journal of Clinical and Aesthetic Dermatology|July 16, 2026
Efficacy and Safety of Tildrakizumab in Elderly Patients With Psoriasis: A Narrative ReviewAlice B Gottlieb, Joseph F MerolaPageof 74